BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 23766865)

  • 1. Role of glutathione in cancer progression and chemoresistance.
    Traverso N; Ricciarelli R; Nitti M; Marengo B; Furfaro AL; Pronzato MA; Marinari UM; Domenicotti C
    Oxid Med Cell Longev; 2013; 2013():972913. PubMed ID: 23766865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione dysregulation and the etiology and progression of human diseases.
    Ballatori N; Krance SM; Notenboom S; Shi S; Tieu K; Hammond CL
    Biol Chem; 2009 Mar; 390(3):191-214. PubMed ID: 19166318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione metabolism in cancer progression and treatment resistance.
    Bansal A; Simon MC
    J Cell Biol; 2018 Jul; 217(7):2291-2298. PubMed ID: 29915025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione Synthesis in Cancer Cells.
    Kalinina EV; Gavriliuk LA
    Biochemistry (Mosc); 2020 Aug; 85(8):895-907. PubMed ID: 33045950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Glutathione Metabolism: Partner in Crime in Anticancer Therapy.
    Desideri E; Ciccarone F; Ciriolo MR
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA Regulation of Glutathione Homeostasis in Cancer Initiation, Progression and Therapy Resistance.
    Marengo B; Pulliero A; Izzotti A; Domenicotti C
    Microrna; 2020; 9(3):187-197. PubMed ID: 31849293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione system in animal model of solid tumors: From regulation to therapeutic target.
    Corso CR; Acco A
    Crit Rev Oncol Hematol; 2018 Aug; 128():43-57. PubMed ID: 29958630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: An evidence-based view.
    El Sayed SM; Baghdadi H; Zolaly M; Almaramhy HH; Ayat M; Donki JG
    Med Hypotheses; 2017 Mar; 100():67-77. PubMed ID: 28236852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The malaria parasite supplies glutathione to its host cell--investigation of glutathione transport and metabolism in human erythrocytes infected with Plasmodium falciparum.
    Atamna H; Ginsburg H
    Eur J Biochem; 1997 Dec; 250(3):670-9. PubMed ID: 9461289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance.
    Chun KS; Kim DH; Surh YJ
    Cells; 2021 Mar; 10(4):. PubMed ID: 33808242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted Roles of Glutathione and Glutathione-Based Systems in Carcinogenesis and Anticancer Drug Resistance.
    Hatem E; El Banna N; Huang ME
    Antioxid Redox Signal; 2017 Nov; 27(15):1217-1234. PubMed ID: 28537430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of cellular glutathione homeostasis for trivalent inorganic arsenite-induced oxidative damage in human bronchial epithelial cells.
    Jiang X; Chen C; Liu Y; Zhang P; Zhang Z
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Aug; 770():35-45. PubMed ID: 25344162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular glutathione level does not predict ovarian cancer cells' resistance after initial or repeated exposure to cisplatin.
    Nikounezhad N; Nakhjavani M; Shirazi FH
    J Exp Ther Oncol; 2017 May; 12(1):1-7. PubMed ID: 28472558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
    Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
    Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione, an Antioxidant Tripeptide: Dual Roles in Carcinogenesis and Chemoprevention.
    Narayanankutty A; Job JT; Narayanankutty V
    Curr Protein Pept Sci; 2019; 20(9):907-917. PubMed ID: 30727890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses.
    Daga M; Ullio C; Argenziano M; Dianzani C; Cavalli R; Trotta F; Ferretti C; Zara GP; Gigliotti CL; Ciamporcero ES; Pettazzoni P; Corti D; Pizzimenti S; Barrera G
    Free Radic Biol Med; 2016 Aug; 97():24-37. PubMed ID: 27184956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of protein S-Glutathionylation in cancer progression and development of resistance to anti-cancer drugs.
    Pal D; Rai A; Checker R; Patwardhan RS; Singh B; Sharma D; Sandur SK
    Arch Biochem Biophys; 2021 Jun; 704():108890. PubMed ID: 33894196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin affects glutathione levels and redox ratio in human aortic endothelial cells not through oxidation but formation and cellular export of quercetin-glutathione conjugates and upregulation of glutamate-cysteine ligase.
    Li C; Zhang WJ; Choi J; Frei B
    Redox Biol; 2016 Oct; 9():220-228. PubMed ID: 27572418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of glutathione/glutathione disulphide ratio and S-glutathionylated proteins in human blood, solid tissues, and cultured cells.
    Giustarini D; Colombo G; Garavaglia ML; Astori E; Portinaro NM; Reggiani F; Badalamenti S; Aloisi AM; Santucci A; Rossi R; Milzani A; Dalle-Donne I
    Free Radic Biol Med; 2017 Nov; 112():360-375. PubMed ID: 28807817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glutathione system in Parkinson's disease and its progression.
    Bjørklund G; Peana M; Maes M; Dadar M; Severin B
    Neurosci Biobehav Rev; 2021 Jan; 120():470-478. PubMed ID: 33068556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.